Skip to main content Skip to main navigation menu Skip to site footer

Karakteristik faktor penyebab hiperbilirubinemia pada neonatus di RSIA Puri Bunda Tabanan, Bali Tahun 2021

Abstract

Background: Neonatal hyperbilirubinemia is a clinical problem that often occurs in neonates, 60% occurs in term neonates and 80% in preterm neonates.. There are non pathological and pathological hyperbilirubinemia. Unconjugated hyperbilirubinemia caused by 4 board groups, which are increased bilirubin production, deficiency of hepatic uptake, impaired bilirubin conjugation, and increased enterohepatic circulation. The purpose of this study was to determine the characteristics of the factors causing hyperbilirubinemia.

Methods: This study used a restrospective cross-sectional method by taking 1 year data, from June 2020 until May 2021. Amount of samples was 146 neonates with diagnosis of hyperbilirubinemia and receiving intensive phototherapy treatment in the Intermediate Room and Neonatal HCU at Puri Bunda Tabanan Mother and Child Hospital. The causative factors collected were ABO incompatibility, prematurity, neonatal asphyxia, breastfeeding jaundice, breastmilk jaundice, low birth weight baby, cephal hematome, and neonatal sepsis. Data collected through medical record and analyzed, subsequently explained descriptively with table.

Result: The result show that from 146 samples that met the inclusion criteria, the most causative factor of hyperbilirubinemia was ABO incompatibility 29 (19.9%), prematurity 16 (11%), low birth weight 15 (10.3%), breastfeeding jaundice 15 (10.3%), neonatal sepsis 15 (10.3%), breastmilk jaundice 12 (8.2%), neonatal asphyxia 7 (4.8%), and no sample with cephal hematome.

Conclusion: Factors causing hyperbilirubinemia found at Puri Bunda Tabanan Mother and Child Hospital were ABO icompatibility as the most common cause and neonatal asphyxia as the least cause.

 

Pendahuluan: Hiperbilirubinemia neonatal merupakan permasalahan klinis yang sering terjadi pada neonatus, sekitar 60% terjadi pada neonatus aterm dan 80% pada neonatus preterm. Kernicterus sebagai komplikasi dari hiperbilirubinemia memiliki angka kematian 10% dan morbiditas jangka panjang 70%. Hiperbilirubinemia ada yang non patologis dan patologis. Unconjugated hyperbilirubinemia disebabkan oleh 4 kelompok besar yaitu peningkatan produksi bilirubin, defisiensi uptake hepar, gangguan konjugasi bilirubin, dan peningkatan sirkulasi enterohepatik. Tujuan dari penelitian ini adalah untuk mengetahui karakteristik faktor penyebab hiperbilirubinemia.

Metode: Penelitian ini menggunakan metode cross-sectional retrospective dengan mengambil data selama 1 tahun yaitu periode Juni 2020-Mei 2021. Jumlah sampel sebanyak 146 neonatus dengan diagnosis hiperbilirubinemia dan mendapatkan tatalaksana fototerapi di ruang Intermediate dan HCU Neonatus di RSIA Puri Bunda Tabanan. Faktor penyebab yang dikumpulkan yaitu inkompatibilitas ABO, prematuritas, asfiksia neonatorum, breastfeeding jaundice, breastmilk jaundice, BBLR, cephal hematoma, dan sepsis neonatorum. Data dikumpulkan melalui rekam medis dan dianalisa untuk kemudian disajikan secara deskriptif.

Hasil: Dari 146 sampel yang memenuhi kriteria inklusi, didapatkan penyebab pertama yaitu inkompatibilitas ABO sebanyak 29 (19,9%), prematuritas sebanyak 16 (11%), BBLR sebanyak 15 (10,3%), breastfeeding jaundice sebanyak 15 (10,3%), sepsis neonatorum sebanyak 15 (10,3%), breastmilk jaundice sebanyak 12(8,2%), asfiksia neonatorum sebanyak 7 (4,8%), dan tidak ada penyebab berupa cephal hematoma yang ditemukan.

Simpulan: Faktor penyebab hiperbilirubinemia yang didapatkan di RSIA Puri Bunda Tabanan yaitu inkompatibilitas ABO sebagai penyebab terbanyak dan asfiksia neonatorum sebagai penyebab paling sedikit.

References

  1. Rohsiswatmo R, Amandito R. Hiperbilirubinemia pada Neonatus > 35 Minggu di Indonesia: Pemeriksaan dan Tatalaksana Terkini. Sari Pediatri.2018;10(2):115-22.
  2. Tavakolizadeh R, Izadi A, Seirafi G, Khedmat L, Mojtahedi SY. Maternal risk factors for neonatal jaundice: a hospital-based cross-sectional study in Tehran. 2018;28(3):257-64.
  3. Wijaya FA, Suryawan WB. Faktor risiko kejadian hiperbilirubinemia pada neonatus di ruang perinatologi RSUD Wangaya Kota Denpasar. Medicina. 2019;50(2):357-64.
  4. Lauer BJ, Spector ND. Hyperbilirubinemia in the Newborn. Pediatrics in Review. 2021;32(8): 341-8.
  5. Santosa Q, Mukhson M, Muntafiah A. Evaluasi penggunaan fototerapi konvensional dalam taka laksana hiperbilirubinemia neonatal: efektif, tetapi tidak efisien. Sari Pediatri. 2020;21(6):377-85.
  6. Hosea MK, Etika R, Lestari P. Hyperbilirubinemia treatment of neonatus in Dr. Soetomo Surabaya. Folia Medica Indonesiana. 2015;51(3):183-86.
  7. Parwata WS, Putra PJ, Kardana M, Artana, WS, Sukmawati M. The characteristic of neonatal hyperbilirubinemia before and after phototherapy at Sanglah Hospital, Denpasar, Bali in 2017. Intisari Sains Medis. 2019;10(2):309-12.
  8. Akgul S, Korkmaz A, Yigit S, Yurdakok M. Neonatal hyperbilirubinemia due to ABO incompatibility : does blood group matter?. The Turkish Journal of Pediatrics. 2013;55(5):506-9.
  9. Maulida M, Sari RD, Mustofa S. Hubungan Kejadian Hiperbilirubinemia dengan Inkompatibilitas ABO pada Bayi Baru Lahir di RSUD Abdul Moeloek Provinsi Lampung. Medula. 2021;11(1):27-31.
  10. Garosi E, Mohammadi F, Ranjkesh F. The Relationship between Neonatal Jaundice Maternal and Neonatal Factors. Iranian Journal of Neonatology. 2016;7(1):37-9.
  11. Devi S, Vijaykumar B. Risk factors for neonatal hyperbilirubinemia: a case control study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2017;6(1):198-201.
  12. Olusanya BO, Osibanjo FB, Slusher TM. Risk factor for severe neonatal hyperbilirubinemia in low and middle-income countries: a systematic review and meta-analysis. PloS ONE. 2015;10(2):4-10.
  13. Centers for Disease Control and Prevention. Jaundice. 2020. Available at : https://www.cdc.gov/breastfeeding/breastfeeding-special-circumstances/maternal-or-infant-illnesses/jaundice.html
  14. Halisanti O. Hubungan antara sepsis neonatorum dengan terjadinya ikterus neonatorum di RSUD Karanganyar. Fakultas Kedokteran Universitas Muhammadiyah Jakarta. 2017
  15. Aynalem S, Abayneh M, Metaferia G, Demissie AG, Gidi NW, Demtse AG, dkk. Hyperbilirubinemia in preterm infants admitted to neonatal intensive care units in Ethiopia. Global Pediatric Health. 2020;7:1-8.
  16. Puspita N. Pengaruh berat badan lahir rendah terhadap kejadian ikterus neonatorum di Sidoarjo. Jurnal Berkala Epidemiologi. 2018;6(2):174-81.
  17. Huang MJ, Kua KE, Teng HC, Tang KS, Weng HW, Huang CS. Risk factors for severe hyperbilirubinemia in neonates. Pediatric Research. 2004;56(5):682-9.
  18. Suradi R, Letupeirissa D. Air susu ibu dan ikterus. 2013. Available at : https://www.idai.or.id/cari?search=air+susu+ibu+dan+ikterus&id=291
  19. Muchowski KE. Evaluation and treatment of neonatal hyperbilirubinemia. American Family Physician. 2014;89(11):873-77.
  20. Saptanto A, Kurniati ID, Khotijah S. Asfiksi meningkatkan kejadian hiperbilirubinemia patologis pada bayi di RSUD Tugurejo Semarang. Fakultas Kedokteran Universitas Muhammadiyah Semarang. 2016.
  21. Mojtahedi SY, Izadi A, Seirafi G, Khedmat L, Tavakolizadeh R. Risk factors associated with neonatal sectional study from Iran. 2018;6(8):1387-93.
  22. Scrafford. Incidence and risk factors for neonatal jaundice among newborns in Southern Nepal. Tropical Medicine and International Health. 2013;18(2):1317-28.
  23. Birth Injury Help Center. Complications from cephalhematomas. Available at : https://www.birthinjuryhelpcenter.org/cephalohematoma-complications.html

How to Cite

Astariani, I., Artana, I. W. D., & Suari, N. M. R. (2021). Karakteristik faktor penyebab hiperbilirubinemia pada neonatus di RSIA Puri Bunda Tabanan, Bali Tahun 2021. Intisari Sains Medis, 12(3), 917–920. https://doi.org/10.15562/ism.v12i3.1174

HTML
255

Total
397

Share

Search Panel

Intan Astariani
Google Scholar
Pubmed
ISM Journal


I Wayan Dharma Artana
Google Scholar
Pubmed
ISM Journal


Ni Made Rini Suari
Google Scholar
Pubmed
ISM Journal